Research programme: psychotherapeutics - PLIVA d.d.Alternative Names: PLR 21; PLR 21a; PLR 21b
Latest Information Update: 16 Aug 2007
$50 / €47 *
At a glance
- Originator PLIVA d.d.
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Major depressive disorder; Psychotic disorders
Most Recent Events
- 15 Apr 2005 Preclinical trials in Depression in Croatia (unspecified route)
- 15 Apr 2005 Preclinical trials in Psychotic disorders in Croatia (unspecified route)